To ensure sustainable growth, and to realize our long-term strategic vision of developing Santen into a specialized pharmaceutical company with global presence, we are committed to the protection and improvement of eyesight and the health of patients. Focusing our efforts on the ophthalmic field Santen hopes to advance treatments by delivering innovative products and services to patients and medical professionals worldwide.
To realize this long-term strategic vision, we are strengthening our pipeline of compounds for development, building a global clinical development system, and investing in the development of new businesses in the rapidly growing markets in Europe and China, as well as in Japan, where we can best maximize our strengths.
There are still many countries and regions in the world where ophthalmic treatments are not sufficiently provided and where medical needs are unmet, particularly for the treatment of retinal disorders. I believe that Santen has a great responsibility to address such unmet needs while meeting the expectation of all stakeholders, and in particular patients and their loved ones.